Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency
The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.
Abstract
Although the use of the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency is well established, diagnostic peak GH cut-points for other commonly used GH stimulation tests are less clearly established. Despite that fact, the majority of patients in the United States who are evaluated for GH deficiency do not undergo insulin tolerance testing. The aim of this study was to evaluate the relative utility of six different methods of testing for adult GH deficiency currently used in practice in the United States and to develop diagnostic cut-points for each of these tests. Thirty-nine patients (26 male, 13 female) with adult-onset hypothalamic-pituitary disease and multiple pituitary hormone deficiencies were studied in comparison with age-, sex-, estrogen status-, and body mass index-matched control subjects (n = 34; 20 male, 14 female). A third group of patients (n = 21) with adult-onset hypothalamic-pituitary disease and no more than one additional pituitary hormone deficiency was also studied. The primary end-point was peak serum GH response to five GH stimulation tests administered in random order at five separate visits: ITT, arginine (ARG), levodopa (L-DOPA), ARG plus L-DOPA, and ARG plus GHRH. Serum IGF-I concentrations were also measured on two occasions. For purposes of analysis, patients with multiple pituitary hormone deficiencies were assumed to be GH deficient. Three diagnostic cut-points were calculated for each test to provide optimal separation of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While interpreting GH values, one should also consider multiple factors, including nutritional and hormonal status, exercise, body weight, and age, all of which may influence pituitary GH secretion (85,86).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [86]
Citations
Cites
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“Each one unit increase in BMI has been shown to be associated with a 6% decrease in 24-h GH secretion (35).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 1×
“Obesity suppresses GH release, with 24-h GH levels in obese men reduced by 75% in comparison with age-matched normal weight subjects (34).”
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414 · cited 4×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundInfluentialDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-690 · Cited by 352 · cited 1×
“GH therapy was not administered for at least one month before study entry, based on data that demonstrate that serum IGF-I levels return to nearbaseline within 48 h after cessation of GH (22).”
MethodArginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
BackgroundWhich Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?
Hartman, M. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.477 · Cited by 319
Self-citationAimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., & Ghigo, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4837 · Cited by 272 · cited 10×
“cut-point of 9 g/liter (3, 5), this test has been reported to be”
BackgroundInfluentialNew approach to the diagnosis of growth hormone deficiency in adults
Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340352 · Cited by 257 · cited 3×
“Interestingly, two studies have reported higher peak GH levels to ARG-GHRH than to ITT, a finding not seen in our study (5, 15).”
BackgroundResultToogood, A. A., Beardwell, C. G., & Shalet, S. M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02583.x · Cited by 219 · cited 4×
“To define diagnostic cutpoints for each test, we assumed that the MPHD patients were GH deficient, based on prior studies demonstrating that such patients have an approximately 90% chance of having severe GHD with the ITT (20, 21).”
BackgroundMethodInfluentialArginine-Initiated Release of Human Growth Hormone: Factors Modifying the Response in Normal Man
Merimee, T. J., Rabinowitz, D., & Fineberg, S. E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196906262802603 · Cited by 208 · cited 1×
“Many investigators have evaluated ARG alone as a provocative test of GH secretion in adults (11, 12, 43, 44).”
BackgroundPulsatile growth hormone release in normal women during the menstrual cycle
Faria, A. C. S., Bekenstein, L. W., Booth, R. A., Vaccaro, V. A., Asplin, C. M., Veldhuls, J. D., Thorner, M. O., & Evans, W. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02270.x · Cited by 194 · cited 1×
“Finally, pulsatile and stimulated GH levels may be higher in the preovulatory and luteal phase of the menstrual cycle than during the follicular phase (54).”
BackgroundGH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults
Popovic, V., Leal, A., Micic, D., Koppeschaar, H. P., Torres, E., Paramo, C., Obradovic, S., Dieguez, C., & Casanueva, F. F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02755-0 · Cited by 185 · cited 1×
“Subsequent studies will be needed to confirm these promising initial findings and to evaluate the proposed cut-points, which are higher than with ITT (14, 56, 57).”
BackgroundHilding, A., Hall, K., Wivall-Helleryd, I.-L., Sääf, M., Melin, A.-L., & Thorén, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5793 · Cited by 182 · cited 1×
“An IGF-I level below a certain cut-point might be useful for the diagnosis of GHD, especially in childhood-onset or young adult-onset GHD patients (50, 52).”
BackgroundClasey, J. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3845 · Cited by 167 · cited 1×
“The amount of abdominal visceral fat is a stronger predictor of 24-h GH release than is total percentage body fat (36).”
BackgroundSelf-citationBeyond the somatopause: growth hormone deficiency in adults over the age of 60 years
Toogood, A. A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.460 · Cited by 160 · cited 3×
“Many investigators have evaluated ARG alone as a provocative test of GH secretion in adults (11, 12, 43, 44).”
BackgroundJones, S. L., Trainer, P. J., Perry, L., Wass, J. A. H., Besser, G. M., & Grossman, A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03793.x · Cited by 159
Rahim, A., Toogood, A. A., & Shalet, S. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00855.x · Cited by 159 · cited 3×
“Clonidine alone is clearly not adequate, as many normal individuals have no detectable GH response, or show the same response as to placebo (12, 47).”
BackgroundSvensson, J., Johannsson, G., & Bengtsson, B. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1851001.x · Cited by 134
Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test
Hoeck, H. C., Vestergaard, P., Jakobsen, P. E., & Laurberg, P. T. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330305 · Cited by 124 · cited 1×
“However, the peak GH response to ITT does not correlate with the degree of hypoglycemia in healthy adults (53).”
BackgroundEndocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: A review
Fish, H. R., Chernow, B., & O'Brian, J. T. (1986) · Metabolism · doi:10.1016/0026-0495(86)90245-3 · Cited by 117 · cited 1×
“Patients with contraindications to hypoglycemia such as seizures and ischemic heart disease are not considered candidates, and patient safety requirements make it a labor-intensive procedure (37, 38).”
BackgroundCordido, F., Diéguez, C., & Casanueva, F. F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1361 · Cited by 108 · cited 1×
“In addition, decreased responsiveness to stimulation tests such as GHRH, ITT, ARG, lDOPA, and ARG-GHRH has been demonstrated in subjects with obesity and/or abdominal adiposity (8, 10, 17).”
BackgroundVestergaard, P., Hoeck, H. C., Jakobsen, P., & Laurberg, P. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979000 · Cited by 104 · cited 1×
“Up to a 6-fold difference in peak GH has been demonstrated on different days in healthy adults undergoing ITTs, regardless of the degree of hypoglycemia (16, 39).”
BackgroundMarzullo, P., Somma, C. D., Pratt, K. L., Khosravi, J. M., Diamandis, A., Lombardi, G., Colao, A. A. L., & Rosenfeld, R. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7628 · Cited by 104
Colao, A., Cerbone, G., Pivonello, R., Aimaretti, G., Loche, S., Somma, C. D., Faggiano, A., Corneli, G., Ghigo, E., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5605 · Cited by 103
Baum, H. B. A., Biller, B. M. K., Katznelson, L. J., Oppenheim, D. S., Clemmons, D. R., Cannistraro, K. B., Schoenfeld, D., Best, S. A., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550799 · Cited by 98
Self-citationEddy, R. L., Gilliland, P. F., Ibarra, J. D., McMurry, J. F., & Thompson, J. Q. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90595-6 · Cited by 94 · cited 1×
“These older studies also employed GH RIAs, producing higher absolute values than assays that are now commonly used (6, 7).”
MethodHilding, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.2013 · Cited by 94
A computer program for non-parametric receiver operating characteristic analysis
Vida, S. (1993) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(93)90004-5 · Cited by 83
Valetto, M. R., BELLONE, J., Baffoni, C., Savio, P., Aimaretti, G., Gianotti, L., Arvat, E., Camanni, F., & Ghigo, E. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350568 · Cited by 82 · cited 2×
“Thus, it has been considered the best diagnostic alternative to the ITT (3, 40, 41).”
BackgroundMethodGhigo, E., BELLONE, J., Mazza, E., IMPERIALE, E., Massimo, P., Valente, F., Lala, R., Sanctis, C. D., & Camanni, F. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00923.x · Cited by 82 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
BackgroundBates, A. S., Evans, A. J., Jones, P. J. H., & Clayton, R. N. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02652.x · Cited by 81 · cited 4×
“To define diagnostic cutpoints for each test, we assumed that the MPHD patients were GH deficient, based on prior studies demonstrating that such patients have an approximately 90% chance of having severe GHD with the ITT (20, 21).”
BackgroundMethodInfluentialGhigo, E., Massimo, P., Boffano, G. M., Arvat, E., Valente, F., Maccario, M., Mazza, E., & Camanni, F. (1992) · Metabolism · doi:10.1016/0026-0495(92)90220-5 · Cited by 75 · cited 1×
“However, the GH response to ARG-GHRH is decreased in healthy obese subjects (42).”
BackgroundMarzullo, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3001 · Cited by 71
Provocative Tests of Growth-Hormone Release
Lin, T., & Tucci, J. R. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-4-464 · Cited by 67
Andersson, A., Ørskov, H., Ranke, M. B., Shalet, S. M., & Skakkebæk, N. E. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320340 · Cited by 66
Granada, M., Sanmartı́, A., Lucas, A., Salinas, I., Carrascosa, A., Foz, M., & Audı́, L. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11675.x · Cited by 61 · cited 1×
“As a result, the classification of individual subjects as normal or GH deficient may change (32, 33).”
BackgroundGROWTH HORMONE (GH) RESPONSES TO ARGININE AND L‐DOPA ALONE AND AFTER GHRH PRETREATMENT
Page, M. D., Diéguez, C., Valcavi, R., Edwards, C. C., Hall, R., & Scanlon, M. F. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03690.x · Cited by 52
Evaluation of growth hormone release in children using arginine and l-dopa in combination
Weldon, V. V., Gupta, S. K., KLINGENSMITH, G. J., Clarke, W. L., Duck, S. C., Haymond, M. W., & Pagliara, A. S. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80816-x · Cited by 50 · cited 1×
“Children have been shown to have a greater response to the combination of these agents that to either alone, but there have been no controlled data evaluating this combination in adults (48).”
BackgroundPhysiological regulators of growth hormone secretion
Hartman, M. L. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511549304.003 · Cited by 49
Self-citationHoeck, H. C., Vestergaard, P., Jakobsen, P. E., Falhof, J., & Laurberg, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6538 · Cited by 41 · cited 2×
“Up to a 6-fold difference in peak GH has been demonstrated on different days in healthy adults undergoing ITTs, regardless of the degree of hypoglycemia (16, 39).”
BackgroundA Simple Test for Growth Hormone Deficiency in Adults
Mahajan, T., & Lightman, S. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6545 · Cited by 41 · cited 1×
“Subsequent studies will be needed to confirm these promising initial findings and to evaluate the proposed cut-points, which are higher than with ITT (14, 56, 57).”
BackgroundFisker, Jørgensen, Ørskov, & Christiansen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00362.x · Cited by 41 · cited 1×
“Although some investigators have shown total separation of patients from carefully matched control subjects using the ITT (30), others have reported overlap between the groups (13).”
BackgroundGasperi, M., Aimaretti, G., Scarcello, G., Corneli, G., Cosci, C., Arvat, E., Martino, E., & Ghigo, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5904 · Cited by 40 · cited 1×
“Subsequent studies will be needed to confirm these promising initial findings and to evaluate the proposed cut-points, which are higher than with ITT (14, 56, 57).”
BackgroundHow many tests are required to diagnose growth hormone (GH) deficiency in adults?
Lissett, C. A., Thompson, E. G. E., Rahim, A., Brennan, B. M. D., & Shalet, S. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00836.x · Cited by 36 · cited 2×
“The concordance between different tests in an individual patient may be higher in patients with MPHD (28).”
BackgroundPodolsky, S., & SIVAPRASAD, R. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-4-580 · Cited by 36 · cited 1×
“Glucagon injection im is considered a useful alternative to ITT by some investigators, but reported by others as being less effective than ARG (7, 12, 55).”
BackgroundHoeck, H. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1467 · Cited by 34
Thissen, J., Ketelslegers, J. M., & Maiter, D. M. (1996) · PubMed · Cited by 33
Diagnosis of GH deficiency in adults
Ghigo, E., Aimaretti, G., Corneli, G., BELLONE, J., Arvat, E., Maccario, M., & Camanni, F. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80010-5 · Cited by 30 · cited 1×
“Thus, it has been considered the best diagnostic alternative to the ITT (3, 40, 41).”
MethodEffect of L-Dopa on Growth Hormone, Glucose, Insulin, and Cortisol Response in Obese Subjects
Vizner, B., Reiner, Ž., & Sekso, M. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1210205 · Cited by 30 · cited 1×
“In addition, decreased responsiveness to stimulation tests such as GHRH, ITT, ARG, lDOPA, and ARG-GHRH has been demonstrated in subjects with obesity and/or abdominal adiposity (8, 10, 17).”
BackgroundPlasma IGF-I is a useful marker of growth hormone deficiency in adults
Span, J. P. T., PIETERS, G. F. F. M., Sweep, F. C. G. J., Swinkels, L. M., & SMALS, A. G. H. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343588 · Cited by 28 · cited 1×
“An IGF-I level below a certain cut-point might be useful for the diagnosis of GHD, especially in childhood-onset or young adult-onset GHD patients (50, 52).”
BackgroundVariability in growth hormone stimulation tests
Fisker, S., Jørgensen, J. O. L., & Christiansen, J. S. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80006-3 · Cited by 28 · cited 1×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundKoppeschaar, H. P. F., Horn, C., Thljssen, J. H. H., Page, M. D., Diéguez, C., & Scanion, M. F. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02250.x · Cited by 27 · cited 2×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
BackgroundGasperi, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2633 · Cited by 20
Strasburger, C. J. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80008-7 · Cited by 14 · cited 1×
“Another important variable to consider regarding the use of an arbitrary cut-point is the type of GH assay performed (18, 31).”
Background
Research works printed but not linked: 2
- 1998, AACE clinical practice guidelines for growth hormone use in adults and children., Endocr Pract, 4, 165
- Mausner, 1974, Epidemiology, Philadelphia: W. B. Saunders;, 237
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
“(37), however, because the average BMI of their patients”
InfluentialHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Self-citationGrimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
“The insulin tolerance test (ITT) has been validated for the diagnosis of adult GHD [20,168] and persistent”
BackgroundMethodInfluentialMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424
Anterior Pituitary Dysfunction in Survivors of Traumatic Brain Injury
Agha, A., Rogers, B., Sherlock, M., O’Kelly, P., Tormey, W., Phillips, J., & Thompson, C. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0511 · Cited by 390
Metadata
- Authors
- Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L.
- Affiliations
- Harvard University (US)
- Oregon Health & Science University (US)
- University Hospitals of Cleveland (US)
- Cedars-Sinai Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Biller, Beverly M. K.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-05-01
- Volume
- 87
- Issue
- 5
- Pages
- 2067-2079
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2125896595
- Semantic Scholar
- e5209f92424ddb2dfc412b4606bcb9a11bff13d5
- Cited by
- 423
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 25 · 2014: 17 · 2013: 19 · 2012: 17
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- insulin tolerance test, arginine stimulation test, GHRH stimulation test, diagnostic thresholds, sensitivity and specificity, multiple pituitary hormone deficiency, hypothalamic-pituitary disease, insulin-like growth factor I, diagnostic accuracy comparison, pituitary hormone replacement
- MeSH terms
- Adult, Aged, Aging, Arginine, Diagnostic Techniques, Endocrine, Drug Combinations, Female, Humans, Hypoglycemic Agents, Insulin, Insulin-Like Growth Factor I, Levodopa, Male, Metabolic Diseases, Middle Aged, Sensitivity and Specificity, Sex Characteristics, Growth Hormone-Releasing Hormone, Stimulation, Chemical, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.